Search
for
Sort by
Research 31–60 of 423
- Oral medications for central serous chorioretinopathy: a literature review
- The myeloid mineralocorticoid receptor regulates dermal angiogenesis and inflammation in glucocorticoid‐induced impaired wound healing
- A novel actor in skin biology: the mineralocorticoid receptor
- PCOS and Obesity: Contraception Challenges
- Glucocorticoid and Sex Hormone Receptors: Clinical Implications and Therapeutic Relevance
- Acne-Associated Syndromes
- Polycystic ovarian syndrome
- Influence of Genotype and Hyperandrogenism on Sexual Function in Women With Congenital Adrenal Hyperplasia
- Dehydrogenase, Cortisol, Dopamine, Zinc, and Vitamin D3 in Iraqi Patients with Polycystic Ovary Syndrome
- Recent advances in the molecular mechanisms causing primary generalized glucocorticoid resistance
- Case report: A pregnant woman accidental treated with spironolactone in mid-gestation
- Spironolactone
- The Search for the Causes of Common Hyperandrogenism, 1965 to Circa 2015
- Hirsutism and virilization
- Nonclassic congenital adrenal hyperplasia and the heterozygote carrier
- Endocrinopathies and Other Disorders Inducing a Polycystic Ovary Syndrome Phenotype
- Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman
- Congenital adrenal hyperplasia
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- Hypertension's 3 Dilemmas and 3 Solutions: Pharmacology of the Kidney in Hypertension
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Contemporary medical therapy for polycystic ovary syndrome
- Hormone therapy in acne
- Cycle pilaire et alopécie X chez le chien
- Congenital Adrenal Hyperplasia
- Effects of natural products on skin inflammation caused by abnormal hormones secreted by the adrenal gland
- The Utility of Monitoring Potassium in Transgender, Gender Diverse, and Nonbinary Individuals on Spironolactone
- GRowing an Epidermal Tumor
- Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome